17071938

Source:http://linkedlifedata.com/resource/pubmed/id/17071938

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0018284, umls-concept:C0019829, umls-concept:C0050380, umls-concept:C0178602, umls-concept:C0301630
pubmed:issue	2
pubmed:dateCreated	2007-2-7
pubmed:abstractText	We investigated whether administration of full-dose ABVD (Adriamycin, bleomycin, vinblastine, dacarbazine) chemotherapy without growth factors, and irrespective of the granulocyte count, caused treatment delays or increased the number of infective episodes, in patients with Hodgkin's lymphoma (HL).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Bleomycin, http://linkedlifedata.com/resource/pubmed/chemical/Dacarbazine, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0923-7534
pubmed:author	pubmed-author:BoletiEE, pubmed-author:MeadG MGM
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	376-80
pubmed:meshHeading	pubmed-meshheading:17071938-Adolescent, pubmed-meshheading:17071938-Adult, pubmed-meshheading:17071938-Aged, pubmed-meshheading:17071938-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17071938-Bleomycin, pubmed-meshheading:17071938-Dacarbazine, pubmed-meshheading:17071938-Disease-Free Survival, pubmed-meshheading:17071938-Dose-Response Relationship, Drug, pubmed-meshheading:17071938-Doxorubicin, pubmed-meshheading:17071938-Female, pubmed-meshheading:17071938-Granulocytes, pubmed-meshheading:17071938-Hodgkin Disease, pubmed-meshheading:17071938-Humans, pubmed-meshheading:17071938-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:17071938-Male, pubmed-meshheading:17071938-Middle Aged, pubmed-meshheading:17071938-Retrospective Studies, pubmed-meshheading:17071938-Treatment Outcome, pubmed-meshheading:17071938-Vinblastine
pubmed:year	2007
pubmed:articleTitle	ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors.
pubmed:affiliation	Department of Medical Oncology, Southampton General Hospital, CRUK Clinical Centre, Southampton, Hampshire, UK. ekaterini.boleti@suht.swest.nhs.uk
pubmed:publicationType	Journal Article